Back to search

Peptide record

TPDB09251

Antibacterial Anticancer Antifungal Hemolysis Toxicity standard
19 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB09251
Antibacterial Anticancer Antifungal Hemolysis Toxicity
Anti-infective peptides Cancer-related peptides Toxicity and safety peptides
AntiBP3 Peptipedia Antifungipept CAFPdb dbAMP PD_Hemolysis
standard
No
A 19-aa standard natural multi-activity (Antibacterial, Anticancer, Antifungal, and other sources) peptide sequence curated from AntiBP3, Peptipedia, Antifungipept, and other sources, with an available 3D structural model.
Sequence
FLSLIPKAISAISALANHF
Physicochemical Analysis
C96H153N23O24
RDCEQGMTWYV
A
2013.41
10.10
2
0
12
+1
-2.34
1.216
144.21
Mammalian: 1.1 hour Yeast: 3 min E.coli: 2 min
0
0.00
4
Residue Composition
number
4
A
0
R
1
N
0
D
0
C
0
E
0
Q
0
G
1
H
3
I
3
L
1
K
0
M
2
F
1
P
3
S
0
T
0
W
0
Y
0
V
Amino Acid Distribution
A: 4 R: 0 N: 1 D: 0 C: 0 E: 0 Q: 0 G: 0 H: 1 I: 3 L: 3 K: 1 M: 0 F: 2 P: 1 S: 3 T: 0 W: 0 Y: 0 V: 0
Chemical Descriptors
19
C96H153N23O24
2013.41
10.10
+1
-2.34
1.216
Evidence Records 3 records
Evidence 1 Activity

Activity

50% Hemolysis
Toxicity
34.86 µM
Hemolytic Cytotoxic
50% Hemolysis | 34.86 | µM | target cell: Horse erythrocytes

Target

Horse erythrocytes

Source & Reference

NA
DBAASP
Structure-activity relationship of an antimicrobial peptide, Phylloseptin-PHa: balance of hydrophobicity and charge determines the selectivity of bioactivities. | Drug Des Devel Ther | 2019
Evidence 2 Activity

Activity

% Hemolysis
Toxicity
50 %
Hemolytic Cytotoxic
Hemolytic_activity: Horse erythrocytes:50% Hemolysis=34.86µM | Cytotoxicity: Not available

Target

erythrocytes

Source & Reference

NA
DRAMP
Drug Des Devel Ther. 2019 Jan 23 13:447-458
Evidence 3 Hemolysis

Source & Reference

PD_Hemolysis
PD_Hemolysis